I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

WCLC 2026

We will be contributing to topics related to
-
12:30 AM
Duration 24hrs Seoul, Republic of Korea
Challenges in interpretation of pathologic response in patients with ALK-rearranged NSCLC receiving alectinib in NAUTIKA1
Anjali Saqi, Jamie Chaft, Edward Kadel, Akila Gopalakrishnan, Beiying Ding, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee, Lynette Sholl
01:30 AM
Duration 90mins Seoul, Republic of Korea
NAUTIKA1: pathological response and safety of neoadjuvant entrectinib▼ or atezolizumab + radiation in biomarker-selected NSCLC
Elaine Shum, Amy Cummings, Andreas Saltos, Nisha Mohindra, Eric M. Toloza, Sibo Tian, David Kozono, Nitin Ohri, Katja Schulze, Qian Zhu, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee, Jamie Chaft
06:37 AM
Duration 10mins Seoul, Republic of Korea
Final Analysis of the Phase 3 IMpower030 Study: Perioperative Atezolizumab + Chemotherapy in Resectable Stage IIB–IIIB NSCLC
Benjamin Solomon, Catherine A. Shu, Solange Peters, David Gandara, David P. Carbone, Makoto Nishio, Alessandro Brunelli, Harvey Pass, Anjali Saqi, Maximilian Hochmair, Igor Bondarenko, Rafal Dziadziuszko, Antonio Chella, Christian Schulz, Bertrand Mennecier, Martin Reck, Masashi Kobayashi, Shaun Mohan, Saket Jain, Chenqi Fu, Pao-Chen Li, ​Marcus Ballinger, Barbara J. Gitlitz, Anthony W. Kim​
06:47 AM
Duration 10mins Seoul, Republic of Korea
Neoadjuvant Divarasib Shows Manageable Safety and Promising Activity in Resectable KRAS G12C+ NSCLC: Updated NAUTIKA1 Data
Jamie Chaft, Amy Cummings, Nisha Mohindra, Marcelo V. Negrao, Kai He, So Yeon Kim, Andreas Saltos, ​Tejas Patil, Elaine Shum, Philip Lammers, Katja Schulze, Qian Zhu, Mark Lin, Evelise Brandao, Celina Ngiam, Ilze Bara, Jay M. Lee​
03:12 AM
Duration 10mins Seoul, Republic of Korea
ASTRES: A Phase 2, Single-Arm Study of Atezolizumab in Locally Advanced, Unresectable, Stage III, Non-Small Cell Lung Cancer
Enriqueta Felip, Luis Corrales, Yun Fan, Emilio Esteban Gonzalez, Le Thi Le Quyen, Patricia Iranzo, Danielli Matias, Mehmet Ali Nahit Sendur, Anh Pham, Ahmet Sümbül, Martina Vrankar, Gustavo Zerwes, Min Zhou, Shwetha Chiluveru, Anna Greco, Jessie J. Hsu, Polina Zhornikova, Francisco Orlandi
06:32 AM
Duration 5mins Seoul, Republic of Korea
NAUTIKA1: Primary analysis of neoadjuvant alectinib in resectable stage IB−IIIB ALK+ NSCLC
Jay M. Lee, Amy Cummings, Najust Florez, Nisha Mohindra, Dennis Wigle, Jules Lin, Catherine A. Shu, Andreas Saltos, Elaine Shum, Marcelo V. Negrao, Tejas Patil, Lynette Sholl, Anjali Saqi, Edward Kadel, Beiying Ding, Celina Ngiam, Ilze Bara, Jamie Chaft​
04:05 AM
Duration 5mins Seoul, Republic of Korea
Expression and Prognostic Impact of B7-H3 in Patients with Extensive-Stage Small-Cell Lung Cancer
Stephen V. Liu, Charles M. Rudin, Solange Peters, Martin Reck, Shun Lu, Ross A. Soo, Hossein Borgahei, Roy Herbst, Pao-Chen Li, Virginia McNally, Stefanie Morris, Hartmut Koeppen, Barzin Nabet, Minu K. Srivastava, Luis Paz-Ares
Coming soon